SCHEMBL14224669

SCHEMBL14224669

Cn1cc([N+](=O)[O-])cc1-c1nc2cc(O)ccc2[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
NPC1 O15118 5/20 0.49
RAB9A P51151 5/20 0.49
NPBWR1 P48145 8/20 0.47
MAPT P10636 6/20 0.42
POLB P06746 1/20 0.42
CHRM4 P08173 1/20 0.40
HTR7 P34969 1/20 0.40
MMP2 P08253 4/20 0.40
MMP9 P14780 4/20 0.40
MMP8 P22894 4/20 0.40
HTT P42858 3/20 0.40
MMP13 P45452 3/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
ALDH1A1 P00352 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5333969 0.85 CHEK2 (0.47) MEN1KMT2ANPC1RAB9ANPBWR1
SCHEMBL5559865 0.82 MEN1 (0.47) MEN1KMT2ANPC1RAB9ANPBWR1
SCHEMBL5424701 0.80 SIRT6 (0.47) MEN1KMT2ANPC1RAB9ANPBWR1
SCHEMBL14224502 0.80 MAPT (0.49) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL14224670 0.79 AMY1A (0.40) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL8601049 0.78 CHEK2 (0.58) MEN1KMT2ANPC1RAB9ANPBWR1
SCHEMBL7472352 0.77 MEN1 (0.47) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL15233046 0.76 IRAK4 (0.54) MEN1KMT2ANPC1RAB9ANPBWR1
SCHEMBL7471355 0.76 MAPT (0.43) MEN1KMT2ANPC1RAB9ANPBWR1
SCHEMBL7473157 0.76 MAPT (0.43) MEN1KMT2ANPC1RAB9ANPBWR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS GENESOFT PHARMACEUTICALS, INC. (US) 2008-04-17 US disclosed
US-7265129-B2 Anti-infective biaryl compounds GENESOFT PHARMACEUTICALS, INC. (US) 2007-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS QTRT1, Q6ZSR9, QTRT2 MEN1 4449/4885KMT2A 3292/4885NPC1 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.